Serge Lebecque Selected Research

Ligands

1/2018	Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis.
3/2012	Targeting pattern recognition receptors in cancer immunotherapy.
5/2011	Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.
10/2006	Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Serge Lebecque Research Topics

Disease

15	Neoplasms (Cancer) 01/2021 - 03/2004
4	Inflammation (Inflammations) 01/2021 - 04/2007
3	Neoplasm Metastasis (Metastasis) 05/2011 - 03/2004
3	Melanoma (Melanoma, Malignant) 08/2007 - 03/2004
2	Malignant Mesothelioma 01/2020 - 01/2016
2	Granuloma 01/2018 - 01/2018
2	Breast Neoplasms (Breast Cancer) 05/2011 - 03/2011
1	Adenocarcinoma of Lung 01/2022
1	Neuroblastoma 01/2021
1	Mesothelioma 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 10/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Sarcoidosis (Schaumann Disease) 01/2018
1	Carcinogenesis 07/2013
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 03/2012
1	Mammary Paget's Disease 12/2008
1	Emphysema 10/2006
1	Pneumonia (Pneumonitis) 10/2006
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2006
1	Papillomavirus Infections 02/2006
1	Spontaneous Remission 03/2004
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2004
1	Tertiary Lymphoid Structures 05/2002

Drug/Important Bio-Agent (IBA)

4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 08/2007
4	Toll-Like Receptor 3IBA 01/2020 - 08/2007
4	LigandsIBA 01/2018 - 10/2006
4	ChemokinesIBA 05/2011 - 05/2002
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 08/2007
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 03/2011
3	AntigensIBA 07/2007 - 03/2004
2	Death Domain ReceptorsIBA 01/2021 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 07/2013
2	Chemokine ReceptorsIBA 05/2011 - 04/2007
2	ParaffinIBA 05/2011 - 12/2008
2	AntibodiesIBA 12/2008 - 03/2004
1	AcetylglucosamineIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Uridine Diphosphate (UDP)IBA 01/2022
1	HexosaminesIBA 01/2022
1	Estrogen Receptor alphaIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Caspase 8 (Caspase-8)IBA 01/2021
1	Poly I-CIBA 01/2020
1	Messenger RNA (mRNA)IBA 10/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2018
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2018
1	CadmiumIBA 01/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2013
1	SaltsIBA 07/2013
1	PlatinumIBA 07/2013
1	Doxycycline (Periostat)FDA LinkGeneric 07/2013
1	Pattern Recognition ReceptorsIBA 03/2012
1	CCR6 ReceptorsIBA 05/2011
1	Therapeutic UsesIBA 03/2011
1	Poly A-UIBA 03/2011
1	Double-Stranded RNA (RNA, Double Stranded)IBA 03/2011
1	HLA-DR Antigens (HLA-DR)IBA 12/2008
1	Indicators and Reagents (Reagents)IBA 12/2008
1	fascinIBA 12/2008
1	Toll-Like Receptor AgonistsIBA 08/2007
1	Cytostatic AgentsIBA 08/2007
1	Protein Synthesis InhibitorsIBA 08/2007
1	Cancer VaccinesIBA 08/2007
1	Biological ProductsIBA 07/2007
1	CytokinesIBA 03/2007
1	SmokeIBA 10/2006
1	Isoantigens (Alloantigen)IBA 01/2004

Therapy/Procedure

6	Therapeutics 01/2020 - 06/2004
2	Drug Therapy (Chemotherapy) 01/2020 - 07/2013
2	Immunotherapy 03/2012 - 03/2004
1	Heterologous Transplantation (Xenotransplantation) 07/2013
1	Ligation 03/2007
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2004